Synthesis and antifungal activity of rhodopeptin analogues. 1. Modification of the east and south amino acid moieties

Organic Letters

Volumn 2, Issue 7, 2000, Pages 973-976

  Kawato, Haruko C ^a   Nakayama, Kiyoshi ^a   Inagaki, Hiroaki ^a   Nakajima, Ryohei ^a   Kitamura, Akihiro ^a   Someya, Kazuhiko ^a   Ohta, Toshiharu ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIFUNGAL AGENT; CYCLOPEPTIDE; RHODOPEPTIN B5;

ARTICLE; CHEMISTRY; DRUG EFFECT; FUNGUS; MICROBIOLOGICAL EXAMINATION; RHODOCOCCUS; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

AMINO ACIDS; ANTIFUNGAL AGENTS; FUNGI; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; RHODOCOCCUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034611510     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol005631c     Document Type: Article

References (14)

1. (a) De Lucca, A. J.; Walsh, T. J. Antimicrob. Agents Chemother. 1999, 43, 1.
2. (b) Barrett, J. F.; Klanbert, D. H. Ann. Rep. Med. Chem. 1992, 27, 149.
3. (c) Barrett, J. F.; Hey, R. J.; Peterson, P. K. New strategies in Fungal Disease; Churchill Livingstone: Edinburgh, 1992.
4. (d) Yamaguchi, H.; Kobayashi, G. S.; Takahashi, H. Recent Progress in Antifungal Chemotherapy; Marcell Dekker Inc.: New York, 1991.
5. (e) Balkovec, J. M. Exp. Opin. Invest. Drugs 1994, 3, 65.
6. (a) Chiba, H.; Agematu, H.; Kaneto, R.; Terasawa, T.; Sakai, K.; Dobashi, K.; Yoshioka, T. J. Antibiot. 1999, 52, 695.
7. (b) Chiba, H.; Agematu, H.; Dobashi, K.; Yoshioka. T. J. Antibiot. 1999, 52, 700.
8. Chiba, H.; Agematu, H.; Sakai, K.; Dobashi, K.; Yoshioka, T. J. Antibiot. 1999, 52, 710.
9. Shioiri, T.; Ninomiya, K.; Yamada, S. J. Am. Chem. Soc. 1972, 94, 6203.
10. Furukawa, M.; Okawara, T.; Terawaki, Y. Chem. Pharm. Bull. 1977, 25, 1319.
11. 3 cells per mL. Minimum inhibitory concentration (MIC) was defined as the lowest concentration of a compound which gave no visibly detectable fungal growth.
12. Drug used: amphotericin B (AMPH; Fungizone, Bristol Myers Squibb, New Brunswick, NJ) and fluconazole (FLCZ; Diflucan, Pfizer, New York,) were obtained commercially.
13. Andruszkiewicz, R. Pol. J. Chem. 1988, 62, 257.
14. MTT assay against P388.